Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of June:

• William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 11:20 a.m. (CDT)
• Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 8:40 a.m. (PDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230518005001/en/

Incyte

Media
Catalina Loveman
+1 302 498 6171
[email protected]

Investors
Gregory Shertzer
+1 302 274 4779
[email protected]

Source: Incyte

You May Also Be Interested In

• XDC Network Welcomes NTT DOCOMO GLOBAL as Institutional Masternode Validator
• Noemi Professional US Announces Dual Runner Up Honors for Noemi Innovate at the 2026 ASCP Skin Deep Readers' Choice Awards
• Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides New Details on FF’s EAI Data Factory, Q3 “Four-Core Full-Stack AI” Robotics Practical Deployment Campaign and